Feature Stories
Updates every hour. Last Updated: 23-Jun-2026 19:16 ET (23-Jun-2026 23:16 GMT/UTC)
New ILL top management team has been appointed
Institut Laue-LangevinThe Institut Laue-Langevin (ILL) is delighted to announce the appointment of its new Director and Associate Directors, who will take up their duties on 1st October 2026. Regine Willumeit-Römer will become the new ILL Director, with Ken Andersen and Jacques Jestin continuing at the ILL as Associate Directors.
Project ASCENT at ILL selected for EU funding under "Choose Europe for Science"
Institut Laue-LangevinThe Institut Laue-Langevin (ILL) will lead the ASCENT project, funded at 1.4 M€ by the European Commission as part of the initiative "Choose Europe for Science 2025". The goal is to train the next generation of researchers and sustain Europe’s leadership in neutron science. ASCENT is one of 16 projects (three of them in France) funded under the pilot call of a programme that aims to enhance the attractiveness of research careers in Europe and address the challenge of scientific talent retention. It is also the only project led by a large-scale infrastructure.
Every time Norway scores, the whole city of Bergen shakes
The University of BergenThis Father’s Day carries new meaning for dad who donated part of his liver to his then 7-month-old son on his own birthday
NYU Langone Health / NYU Grossman School of MedicineStudents develop manufacturing software in ORNL–Tennessee Tech partnership
DOE/Oak Ridge National LaboratoryHow a rogue tau protein drives destruction — and how it might be stopped
Howard Hughes Medical InstituteNon-Hermitian quantum mechanics: Uncovering the geometric properties unique to energy-non-conserving systems
Advanced Institute for Materials Research (AIMR), Tohoku University- Journal
- Physical Review Research
Researchers discover cause of neuron excitability in ALS
Les Turner ALS FoundationDigging deep into the molecular mechanisms behind ALS, researchers at the Les Turner ALS Center at Northwestern Medicine have discovered why nerve cells overfire in the disease. Not only that—they have also designed a new drug to stop this overfiring, which could potentially slow or stop the disease from progressing.